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Summary Pleural effusions can be caused by highly different underlying diseases
and are characterized by complex interactions of various local and circulating cells
as well as numerous soluble parameters like interleukins (IL). Knowledge about this
complex network could help to indicate underlying disease. Therefore, we have
investigated immunoreactive concentrations of IL-4, IL-6, IL-11, IL-15, IL-17, IL-18,
and tumor necrosis factor-a (TNF-a) in pleural effusions and peripheral blood from
patients with tuberculosis, bronchial carcinoma and other carcinomas as well as
congestive heart failure (CHF) and pneumonias. To determine the value of cytokine
measurement for differential diagnosis, statistical and fuzzy-logic methods were
applied. Quantitative analysis showed high concentrations of IL-6 and IL-11 only in
pleural effusions. IL-15, IL-17, IL-18 and TNF-a could be detected also in blood
plasma. Lowest amounts were detected in CHF indicating the non-inflammatory
origin of effusions. Statistical analysis did not provide evidence for diagnostic
relevance of singular cytokines. Fuzzy-logic analysis was able to assign patients to
the correct diseases with 80% accuracy using IL-6 and IL-15 measurement. Our results
confirm the pathogenetic role of these cytokines in pleural effusions. Fuzzy-logic-
based procedures may help to characterize and distinguish effusions of unknown
origin even in small patient groups.
& 2003 Elsevier Ltd. All rights reserved.
Introduction
Pleural effusions are the result of a disturbed
equilibrium between production and elimination of
the pleural fluid. The formation of pleural fluid is
influenced by circulating and local inflammatory
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cells, as well as a number of soluble parameters
like interleukins (IL), growth factors, proteinases
and their inhibitors.1–4
Interleukin-4 (IL-4) plays an important role in the
modulation of the immune response in infection
with M. tuberculosis.5 The synthesis of IL-6, having
a wide spectrum of biological activities can be
stimulated by many factors and was found to
increase in the pleural effusions of patients with
pulmonary carcinoma and tuberculosis (TB).6–9 IL-
11 can reduce the production of inflammatory
mediators, inhibit the primary and secondary
immune response in vitro and in vivo, and modulate
specific antigen antibody reactions. It also stimu-
lates the T cell dependent development of specific
immunoglobulin-secreting B cells,10 and because
of its upregulation by inflammatory cytokines it
can play an important role in pulmonary inflam-
mation.11 Recent studies described the induction
of the activity of mononuclear cells of the pleura
and the blood through IL-15 as well as the
increasing of the cytotoxic activity of the effusion-
associated lymphocytes in pleural effusion.12,13 IL-
17 is known to be stimulated by the tuberculin
purified protein derivate (type 1) and is a mediator
produced by activated T lymphocytes that play an
important role in the immune system.14 Lung
fibroblasts and alveolar macrophages are thought
to be the main source of IL-18, that can enhance
the production of interferon-g (IFN-g) and granulo-
cyte-macrophage colony stimulating factor (GM-
CSF) in mononuclear peripheral blood cells, pro-
duction of T helper type 1 cytokines, IL-2, GM-CSF
and IFN-g in T cells, and expression of Fas ligand by
T helper type 1 cells.15 Tumor necrosis factor-a
(TNF-a) shows also a broad spectrum of biological
activities because of the occurrence of its recep-
tors on all cells, including the pleura cells, of the
human body with the exception of the erythro-
cytes, and it is known as a macrophage activating
substance and it additionally plays an important
role with the development of the mycobacterial
granuloma.16,17
A recently published study proved that increased
blood plasma concentrations of ILs can be found in
patients with TB-induced pleural effusions.18
Therefore, we determined cytokines in pleural
effusions and peripheral blood of patients with
TB, bronchial carcinoma (BC) and various carcino-
mas with secondaries to the lung (CA), congestive
heart failure (CHF) and pneumonias (PN).
Because of the fact, that the determination of
parameters like lactate dehydrogenase (LDH) and
total protein are helpful in differentiating exudates
and transudates,19,20 we tried to find out whether
measuring of cytokines would allow further help in
achieving an accurate diagnosis. For data analysis,
a fuzzy-logic supported method was used.
Methods
Patients
In this study, a total of 76 patients (28 women, 48
men, age 66717 years) with pleural effusions due
to TB (n ¼ 16), BC (n ¼ 28), CA (n ¼ 17), CHF
(n ¼ 9) and PN (n ¼ 6) were examined. The clinical
diagnosis of TB and BC was based on clinical,
radiological, microbiological, cytological, or histo-
logical examinations. In addition, malignant cells in
the pleural effusion or in pleural biopsies at the BC
patients were determined. In these patients, the
histological type was adeno carcinoma (n ¼ 12),
non-small cell carcinoma of undeterminated type
(n ¼ 5), small cell carcinoma (n ¼ 4), squamous
cell carcinoma (n ¼ 3) and undifferentiated type
(n ¼ 4). The primary tumors of all carcinoma
patients with secondaries to the lung were adeno-
carcinomas of the breast, stomach, rectum and
colon. The diagnosis of the CHF (n ¼ 9) was based
on radiological and clinical findings, the transuda-
tive nature of the effusion and the exclusion of
other possible etiologies. In one CHF patient an
exudate was verified. Of all patients we have
examined blood plasma and pleural effusion that
were collected at the time of investigation. The
serum of six healthy blood donors served as controls
(CON).
Sample collection
All patients from the Prince of Wales Hospital, the
Haven of Hope Hospital, both Hong Kong, and the
University Hospital and Robert Koch Hospital from
Leipzig, Germany, were consecutively entered into
the study before initiation of the treatment. The
only inclusion criterion was the presence of pleural
effusion. The study has been approved by the
ethical committees of each institution. Informed
consent was obtained from each patient.
Pleural effusions were collected during the first
diagnostic or therapeutic thoracocentesis. The
pleural fluid was placed in tubes containing
ethylene diamine tetra-acetate (EDTA) to a final
concentration of 1mg/ml. A separate portion was
placed in plain tubes for determination of LDH and
total protein. Blood was withdrawn from peripheral
vein and collected in tubes containing EDTA (final
concentration 1mg/ml) or in plain tubes. The
supernatants and cell pellets were separated by
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centrifugation (600g, 30min, 41C). Plasma, serum
and pleural effusion supernatants were aliquotted
and stored at 701C for later analysis.
Laboratory analysis
The total cell, white cell and differential cell
counts (May-Gr .unwald Giemsa stain) were deter-
mined by counting of at least 200 cells under the
light microscope. LDH and total protein concentra-
tions were determined in the effusion supernatants
and in blood serum by automated standard meth-
ods. Immunoreactive concentrations of IL-4, IL-6,
IL-11, IL-15, IL-17, IL-18 and TNF-a were deter-
mined in effusion fluid and blood plasma samples
utilizing commercially available ELISA assays
[Quantikine, R&D Systems GmbH, Wiesbaden, FRG
(IL-4, IL-11, IL-15, IL-17, and IL-18); Immulite,
Euro/DPC Ltd., Llanberis, Gwynedd, UK (IL-6 and
TNF-a)]. The lower detection limits were: IL-4
[10 pg/ml]; IL-6 [5 pg/ml]; IL-11 [8 pg/ml]; IL-15
[1 pg/ml]; IL-17 [15 pg/ml]; IL-18 [12.5 pg/ml];
TNF-a [1.7 pg/ml].
Data analysis
Statistical analysis and data presentation were
performed using SigmaStat and SigmaPlot software
(SPSS Scientific, Erkrath, FRG). All data are
presented as mean7standard error of mean. As
the data were not normally distributed, Wilcoxon
signed-rank-tests were performed for paired sam-
ples and Mann–Whitney U-test for independent
samples. For comparisons of the independent
diagnostic groups, the Kruskal–Wallis one way
analysis of variance of ranks was performed. All P
values of o0:05 were considered as statistically
significant.
To intensify the statistic investigations, multi-
parametric procedures were used. Due to the small
amount of patients it could not be expected that
thereby valid statements for the discrimination of
selected groups of patients could be won. Thus with
the multi-parametric analysis the goal was pur-
sued, to show thesisful possible connections be-
tween the parameters. For the statistic
confirmation of such theses, further investigations
on the basis of new data are necessary. Considering
this restriction for the multi-parametric evalua-
tion, a fuzzy-based classification procedure was
selected. This methodology is characterized by the
fact that the mathematical formalism can be
interpreted as completely specialized linguis-
tic.21,22 Both the development and using of such
classification algorithms are then supported by
rules in the form of ‘‘Ifytheny’’statements23 or
by comparison with known samples in the form of
evaluated reference data.24 These basic principles
promote considerably interdisciplinary co-opera-
tion between the medical profession and computer
scientists, since on the one hand medical specia-
lized knowledge flows into the algorithm develop-
ment, on the other hand the results can be
examined regarding their medical plausibility. In
the case of our fuzzy classificator, the rule-based
method was selected in order to be able to divide
the patients into two different groups (‘‘infec-
tious’’ and ‘‘malignant’’). Into the ‘‘infectious’’
group TB and PN patients were classified and into
the ‘‘malignant’’ group the others. This type of
distribution results from a mathematical processing
method and improves the diagnostic accuracy. An
important characteristic of fuzzy logic is the
substitution of a given ‘‘yes–no’’ decision by a
graded (fuzzy) function. Thus the co-ordination of a
interleukine level to the criterion, e.g. ‘‘malig-
nant’’ would be described in terms of ‘‘morey-
less’’ and not as a sharp cut-off value. Thus it is
possible not to exclude uncertain or apparently
contradictory parameter constellations a priori for
a given allocation, but to weigh the affiliation to
each of the classes as a function of numerical
development. The methodical work procedures for
the development of a fuzzy-based classificator are
in detail described in Ref.25 So-called membership
functions of triangular shape are used in our model
to describe the qualitative relation of each single
marker to the term ‘‘malignant’’ for example. For
the mathematical definition of the rules, inference
algorithms of the MIN–MAX type were used. The
defuzzyfication employed the centre of gravity
method to yield an output variable quantifying
the distinctness of malignancy. The membership
functions and the rules were defined with refer-
ence to all available data. The result represents a
multi-dimensional calculation that is implemented
by an adapted computer program. With the help of
the fuzzy-logic module, the measurements of
different ILs are processed so that for the existence
of a malignant or infectious accompanying illness of
the pleural effusion, a meaningful indicator can be
created. The results of the fuzzy-logic analysis
were plotted on the basis of the receiver-operating
characteristics (ROC) curves, that serve the eva-
luation of the diagnostic value of a parameter. The
specificity and sensitivity are presented here in a
diagram. The diagnostic value of the parameter
was proven by the sensitivity at the 95% and 80%
specificity.
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Results
General characteristics of the pleural
effusions
Total cell number and differentiation of the
effusions was found as expected according to
diagnostic groups. Protein and LDH concentrations
in pleural effusion of CHF patients was significantly
lower in comparison to other diagnostic groups
(Po0:01 each).
On the basis of the measured total protein and
LDH concentrations in serum and pleural effusion,
effusions of the BC, TB, CA and PN patients have
been classified as exudative (ratio pleural effusion/
serum 40.5 for protein and 40.6 for LDH,
respectively) and the effusions of the CHF patients
as transudative.19
Among nine CHF patients was one male patient
whose effusion had to be categorized as exudate
because of high total protein concentration and
LDH ratio on account of a diuretic therapy.
All results of these basic investigations corre-
sponded with generally accepted medical knowl-
edge and are not presented here in detail.
Cytokines
The concentration of all measured cytokines in all
CON sera was under the detection limit and was not
included in our analysis.
The concentrations of IL-4 could also not be
detected and was not included in the analysis.
IL-6 was found in none of the blood samples, but
in all pleural effusions. The highest absolute IL-6
values were found in the effusions of TB and BC
patients (1299077395 and 824377722 pg/ml), the
lowest at the CHF patients (213871730 pg/ml).
We observed following statistically significant
differences between diagnostic groups (BC vs. TB
P ¼ 0:031; BC vs. CHF, P ¼ 0:026; TB vs. CA, P ¼
0:012; TB vs. CHF, Po0:001; CA vs. CHF, P ¼ 0:014;
CA vs. PN, P ¼ 0:036; CHF vs. PN, P ¼ 0:009;
Fig. 1a).
IL-11 was found in only 37 of 76 patients. The
highest values of IL-11 were measured in TB
patients (104.17105.7 pg/ml). CHF patients
showed no positive results. Significant were follow-
ing differences (BC vs. TB, P ¼ 0:008; BC vs. CHF,
P ¼ 0:03; TB vs. CHF, Po0:001; CA vs. CHF, P ¼ 0:01;
CHF vs. PN, P ¼ 0:006; Fig. 1b).
IL-15 could be detected in most plasma samples
and in all pleural effusions. Concentration was
significantly higher in pleural effusions. Highest
absolute values were found in effusions of CA and
BC patients, whereas the lowest IL-15 concentra-
tions were found in the plasma of the CA group.
Both the differences between IL-15 concentrations
in plasma and pleural effusion and between
different diagnostic groups have achieved statisti-
cal significance. Means and P-values are repre-
sented in Fig. 2a.
IL-17 was found only in the pleural effusion of
four of 76 patients (1 BC, 2 PN and 1 CA).
IL-18 concentrations exceeded the detection
limit in only 37 of 76 patients in five plasma and
32 pleural effusion samples (Fig. 2b). The highest
values were found in CA patients. In the CHF and PN
patients, we found no trace of IL-18 in the blood
plasma and only seldom cases of increased con-
centration of this parameter in the pleural effu-
sion. We observed following statistically significant
differences (BC plasma vs. BC effusion, Po0:001;
ARTICLE IN PRESS
0
In
te
rle
uk
in
e-
11
 [p
g/m
l]
0
100
200
300 p = 0.008
p = 0.03
p < 0.001
p = 0.01
p = 0.006
1
(n = 28)
   TB
(n = 16) (n = 17) (n = 9)
PN
(n = 6)BC(n = 28)
 TB
(n = 16) (n = 17) (n = 9) (n = 6)
20000
15000
10000
5000
25000
In
te
rle
uk
in
e-
6 
[pg
/m
l]
(a) (b)
p = 0.014
p = 0.036
p = 0.012
p < 0.001
p = 0.009
p = 0.031
p = 0.026
   CA    BC
500
CHF CHF PN    CA
Figure 1 Box-and-whiskers plot of the concentration of IL-6 (1a) and IL-11 (1b) in the pleural effusion of patients with
BC, TB, CA, CHF and PN. The box content includes values between the 25th and 75th percentiles; the dark line within
the box represents the median; the dotted line represents the mean. The whiskers represent all values except outliers.
P values of significant differences are shown. Precise description of the marked patients can be found in Table 4.
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TB plasma vs. TB effusion, P ¼ 0:025; CA plasma vs.
CA effusion, P ¼ 0:008).
TNF-a was found almost exclusively in patients of
the TB diagnostic group (Fig. 2c). Six of 16 TB
patients had a positive result for TNF-a in the
pleural effusion (146773.17 pg/ml) and three
patients had a TNF-a positive plasma value, without
the pleural effusion’s concentration being raised.
Statistically significant were these differences (BC
vs. TB, P ¼ 0:011 and TB vs. CA, P ¼ 0:006).
Fuzzy-logic analysis
In order to increase the precision of the fuzzy-logic
analysis, we classified negative findings as ‘‘under
detection limit’’. Under this condition, further
analysis could be performed for IL-6, IL-11, and
IL-15 in pleural effusions. The results were plotted
as ROC curves. These curves represent the evalua-
tion of the diagnostic value of a parameter by
specificity (part of the data records, which were
assigned correctly to the comparison group) and
sensitivity (part of the data records, which were
assigned correctly to the illness group). The
diagnostic value of each parameter was investi-
gated by the sensitivity at 95% and 80% specificity.
We examined the individual parameters and per-
formed then a multi-parametric analysis. The
different arrangements of diagnostic groups that
were formed in the single-parameter analysis result
from the mathematical processing. The software
merged patients with similar findings dependent on
included laboratory values.
For IL-6, 72 patients from all five diagnostic
groups (BC, TB, CA, CHF and PN) were analyzed
(Table 1). When determining the cut-off value,
patients with a value under resp. over cut-off could
be assigned to comparison or illness group, respec-
tively. For TB and PN patients, IL-6 was often high,
and for CHF, BC and CA patients it was often low.
Therefore, two classes were assigned as included in
Table 2. Thus 21 TB and PN patients form the group
with often high IL-6 values, and 51 BC, CA and CHF
patients the group with often low IL-6 values.
Because of the upper measuring limit of 20,000pg/ml
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Figure 2 Box-and-whiskers plots of the concentrations of IL-15 (2a), IL-18 (2b) and TNF-a (2c) in the blood plasma
(white boxes) and pleural effusions (gray boxes) of patients with BC, TB, CA, CHF and PN. The box content includes
values between the 25th and 75th percentiles; the dark line within the box represents the median. The whiskers
represent all values except outliers. The horizontal dotted lines represent the mean. Precise description of the marked
patients can be found in Table 4.
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we could achieve the 48% sensitivity at 90%
specificity.
A statistically better situation was observed in
the case of IL-15, where 74 patients could be
analyzed (Table 1). 50 of them (BC, CA, and PN
patients) had often high IL-15 values in comparison
to the other 24 (TB, CHF) patients with often low
IL-15 values (cut-off value 4.75). In the case of this
separation we were able to classify with 95%
specificity and 31% sensitivity. Other combinations
of the patient groups did not show any higher
sensitivity. Data are included in Table 2.
The same procedure did not succeed for IL-11
(Table 1). Only 36 of total 76 patients had positive
IL-11 values in the pleural effusion, and we did not
find any positive IL-11 values at CHF patients. After
the determination of the cut-off value of 206, TB
and CA patients were assigned to the group with
high IL-11 values, and BC and PN patients with low
IL-11 values. No sensitivity could be calculated at
95% specificity. Only at 87% specificity, a sensitivity
of 38% could be found. Due to the fact that the ROC
curve runs near the diagonal, no diagnostic
separation was possible.
By combining ROC curves for IL-6 and IL-15, the
following differential-diagnostic relations could be
shown (Table 2). Based on the classification as
calculated above, neither statistical nor practical
significance could be reached.
In order to increase the sensitivity, we executed
a multi-parametric analysis. The data were divided
again into two classes. The diagnostic groups that
could not be differentiated (‘‘malignant’’ and
‘‘infectious’’) form separate classes in each case
(Table 3, Fig. 3). The results show clearly that the
application of the fuzzy classificator is more
powerful in comparison to the best single para-
meter (IL-6), or the threshold value model combin-
ing cut-off decisions for IL-6 and IL-15. With good
specificity of 90%, the best single parameter (IL-6)
reaches a relatively low sensitivity of 48%. The
threshold value model of IL-6 and IL-15 leads to an
increase of the sensitivity to 55%, being nearly 16%
less sensitive than the fuzzy classificator with a
sensitivity of 71%. For comparison, the specificity of
90% is chosen, since it represents the overall
specificity of IL-6 and IL-15 with a cut-off of 95%
each (0.952¼ 0.903).
For an optimized sensitivity of 88%, specificity of
all classification methods is considerably reduced.
Vice versa, at a chosen high specificity of 95%,
sensitivity is diminished, whereby the fuzzy
classificator is over 42% better than the best
single parameter (Table 3). The area under
the ROC curve (AUC) indicates the power of
classification. The numerical value lies
between 0.5 for data records without separation
ability and 1.0, if the groups can be completely
discriminated. The increase in separation ability
has been confirmed by AUC values, as shown in
Fig. 3.
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Table 1 Classification of the diagnostic groups according to the IL-6, IL-15 and IL-11 concentration.
High Low
IL-6 concentration
Number of patients 21 51 AUC (Wilcox), 0.785
Diagnostic groups TB, PN CHF, BC, CA
IL-15 concentration
Number of patients 50 24 AUC (Wilcox), 0.699
Diagnostic groups BC, CA, PN TB, CHF
IL-11 concentration
Number of patients 21 15 AUC (Wilcox), 0.540
Diagnostic groups TB, CA, CHF BC, PN
BCFbronchial carcinoma; TBFtuberculosis; CAFvarious carcinomas; CHFFcongestive heart failure; PNFpneumonia; and
AUCFarea under the curve.
Table 2 Composition of the results of the ROC
curves for IL-6 and IL-15.
IL-6 IL-15 Comment
High Low Rather TB
High High Rather PN
Low Low Rather CHF
Low High Rather BC or CA
BCFbronchial carcinoma; TBFtuberculosis; CAFvarious
carcinomas; CHFFcongestive heart failure; and
PNFpneumonia.
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Discussion
This study describes the occurrence of selected ILs
in pleural effusions in comparison to plasma levels
in patients with different diseases. High concentra-
tions of IL-6 and IL-11 were found only in pleural
effusions that demonstrate the compartmentaliza-
tion at the site of active disease. IL-15, IL-18 and
TNF-a could be found in pleural effusions as well as
in plasma, but only in the case of IL-15 the
differences of concentrations between the diag-
nostic groups reached statistical significance.
IL-4 could not be found in any of our patients
including TB group. Although the immune response
against M. tuberculosis depends on the balance
between Th1/Th2 response (including IFN-g; IL-10),
the health state of the patient and other
factors,5,26 this parameter seems to be without
diagnostic value in this setting.
IL-6 was increased in pleural effusions of all
patients irrespective of origin. The explanation of
high concentrations of this parameter in the pleural
compartment in different illnesses compared to
plasma would be their increased production and
secretion by local cells. Fibroblasts, endothelium
cells, inflammatory or even tumor cells themselves
can be such an IL-6 source.4 Lowest IL-6 values
were found in CHF effusions (non-inflammatory
origin), the highest measured occurred in TB
patients.
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Table 3 Individual values from the ROC curve for the comparison of the sensitivity and specificity.
Procedure Parameter Sensitivity (%) Specificity (%)
Comparison at high
sensitivity
Fuzzy classificator 88 66
Threshold value 88 56
IL-6 88 52
Comparison at high
specificity
Fuzzy classificator 67 95
Threshold value 53 95
IL-6 25 95
Point chosen for further
analyses
Fuzzy classificator 71 90
Threshold value 55 90
IL-6 48 90
The bold-faced values indicate the values used as basis for comparison (same sensitivity or same specificity,
respectively).Threshold valueFsee text.
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IL-11 could be found only in pleural effusions,
similar to IL-6. There were no positive results in
CHF patients. Highest concentrations were found in
TB patients. Increased IL-11 synthesis mainly occurs
during an inflammatory or a neoplasmatic process.
In respiratory epithelial and fibroblast cells, the
production of IL-11 is upregulated by inflammatory
cytokines and therefore it is thought to play an
important role in pulmonary inflammation.11 IL-11
also promotes the development of T cell dependent
Ig-secreting B cells. This process could play an
important role in the immune response against M.
tuberculosis.
Increased IL-15 values were measured in pleural
effusions and plasma of most patients. It is
important that the IL-15 concentration was clearly
higher in pleural effusions than in plasma indicating
local secretion. Because this cytokine has many
various sources, complex local and also systemic
effects occur in different diseases, causing higher
concentrations of other cytokines and attracting
immune cells to inflammatory foci, especially in
pleural space.12,13 The highest quantities of the IL-
15 were measured in BC and CA patients. This
confirms the results of other studies that described
the induction of the activity of mononuclear cells
of the pleura and the blood through IL-15.12 The
high IL-15 concentration that was found in TB
patients confirms the results that infection of the
macrophages by M. tuberculosis causes a raised IL-
15 secretion, modulating immune response from
a=b to g=d T cells.27
Although IL-17 is a cytokine with complex and
important regulatory functions in the immune
system, we found only few patients with positive
results in our study. Because activated cells secrete
IL-17, we nearly exclusively detected this para-
meter in singular patients with thoracic empyema.
IL-18 concentrations in pleural effusions were
increased in all diagnostic groups. There were also
patients with systemically high IL-18 values
(4150 pg/ml), but they had always an acute
accompanying process (PN) or a high age. In many
studies it was shown that IL-18 has synergistic
effects with IL-1228 and thus plays an important
role in intracellular infections (upregulation of the
Th1 response). Indeed, most of TB patients in-
vestigated here did not express pathological con-
centration of this marker. The same situation was
seen in BC and CA patients. Although IL-18 has anti-
tumor activity by stimulating IFN-g production in
Th1 and NK cells29 and antibody production in B
lymphocytes,30 we did not observe an increase of
this cytokine in these patients. We conclude
therefore that this substance is not well suitable
as a diagnostic marker.
TNF-a was found almost exclusively in TB
patients and in individual patients with advanced
consuming accompanying illnesses, high age or
thoracic empyema. However, it was found only in
46% of all TB patients and therefore cannot be
considered as a diagnostic cytokine.
Data analysis with fuzzy logic is one of the first
successful attempts to emulate human thinking
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Table 4 Characteristics of patients with outlying cytokine results.
Pat.
number
Age Sex Characteristics of the patient
1 65 M A smoker with squamous cell carcinoma (stage II; T2 N1 M0) and the bad
general health state (Karnofsky Index¼ 60)
2 59 W An adeno carcinoma of the lung (stage IV) after chemotherapy with
pneumonia as accompanying illness
3 77 M An undifferentiated bronchial carcinoma and a very bad general health state
(Karnofsky Index¼ 20)
4 68 W An adeno carcinoma (stage III B) and the good general health state, at which
one neither surgical interventions nor radiating and chemotherapy were
made
5 31 M A non-smoker with a positive histological tuberculosis diagnosis and manifest
lymphopenia (4%)
6 84 M A carcinoma of unknown primum and good general health state
7 81 M A stomach adeno carcinoma with lymph node infestation and multiple
metastases in the lung. Good general health state (Karnofsky Index¼ 80)
8 78 M Tuberculosis and multiple accompanying illnesses. Bad general health state of
the patient
9 59 M Thoracic empyema. In spite of an acute inflammation in a good general
health state (Karnofsky Index¼ 90)
mFmale; and wFfemale.
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procedure.22 Probably therefore the first fuzzy-
logic applications were used in the medical field,31
to develop diagnostic models on the basis of the
clinical and/or laboratory findings.32–34 It is im-
portant that this electronically supported diagnos-
tic procedure also involves the explicit knowledge
of the physician. The results acquired by fuzzy
procedures were essentially better evaluated in
comparison with normal evaluation methods of
clinical data,35 mainly in smaller data sets. Larger
collectives can be described by multi-variate
statistical analysis and are expected to confirm
fuzzy results. They should obtain an important
place during the evaluation of the laboratory data,
because they do not replace the knowledge of the
physician, but try to help him to objectify and
validate his medical decisions.
In summary, IL-6 and IL-11 were found in high
concentrations only in the pleural effusions demon-
strating their compartmentalization at the site of
active disease. IL-15, IL-18 and TNF-a could be
found in pleural effusions as well as in plasma. As a
pathogenetic aspect, prominent role of T cells (IL-
15) as well as macrophages and other IL-6 produ-
cing cells in induction of pleural effusions was
confirmed. We could not find any sharp relations
between single markers and the accompanying
illnesses. Therefore, we attempted to use various
inflammation markers from the pleural effusion and
other clinical parameters by means of the fuzzy-
logic modelling for the estimating of the accom-
panying illness. Such analyses have recently been
done on the field of the bronchial and pancreatic
carcinoma diagnostics with a tumor marker analy-
sis.36,37 We examined different combinations of the
ILs and found out that the results preserved by
means of fuzzy classificator show a notable increase
(23%) of the sensitivity and specificity in compar-
ison with the best single markers. By means of the
measured IL-6 and IL-15 concentration in the
effusion, it was possible to assign the examined
patients to the correct illness group with 80%
accuracy. No studies that applied this method for
the pleural effusion differential diagnosis are at
this time known to us. Our results are, however, an
interesting point for the further research on this
field, and are expected to be continued by
investigating a large group of patients.
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